116 related articles for article (PubMed ID: 9731434)
1. [Mutations of the p53 suppressor gene in gastric adenocarcinoma].
Aranda M; Náquira N; Karque R; Mendoza H; Sepúlveda C; Silva C
Rev Med Chil; 1998 May; 126(5):525-32. PubMed ID: 9731434
[TBL] [Abstract][Full Text] [Related]
2. Mutations of p53 gene in gastric carcinoma in Taiwan.
Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ
Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797
[TBL] [Abstract][Full Text] [Related]
3. p53 gene mutations in human gastric cancer: wild-type p53 but not mutant p53 suppresses growth of human gastric cancer cells.
Matozaki T; Sakamoto C; Suzuki T; Matsuda K; Uchida T; Nakano O; Wada K; Nishisaki H; Konda Y; Nagao M
Cancer Res; 1992 Aug; 52(16):4335-41. PubMed ID: 1322785
[TBL] [Abstract][Full Text] [Related]
4. Low presence of p53 abnormalities in H pylori-infected gastric mucosa and in gastric adenocarcinoma.
Berloco P; Russo F; Cariola F; Gentile M; Giorgio P; Caruso ML; Valentini AM; Di Matteo G; Di Leo A
J Gastroenterol; 2003; 38(1):28-36. PubMed ID: 12560919
[TBL] [Abstract][Full Text] [Related]
5. [Point mutation of TP53 suppressor gene in pre-neoplastic and neoplastic lesions of the stomach].
Araya JC; Roa JC; Villaseca MA; Roa I; Guzmán P; Alvarado C; Melo A
Rev Med Chil; 2003 Apr; 131(4):359-65. PubMed ID: 12870229
[TBL] [Abstract][Full Text] [Related]
6. Morphologic, histologic, and molecular similarities between adenocarcinomas arising in the gastric stump and the intact stomach.
Safatle-Ribeiro AV; Ribeiro Júnior U; Reynolds JC; Gama-Rodrigues JJ; Iriya K; Kim R; Bakker A; Swalsky PA; Pinotti HW; Finkelstein SD
Cancer; 1996 Dec; 78(11):2288-99. PubMed ID: 8940997
[TBL] [Abstract][Full Text] [Related]
7. Age-associated increase of codon 72 Arginine p53 frequency in gastric cardia and non-cardia adenocarcinoma.
Zhang ZW; Newcomb P; Hollowood A; Feakins R; Moorghen M; Storey A; Farthing MJ; Alderson D; Holly J
Clin Cancer Res; 2003 Jun; 9(6):2151-6. PubMed ID: 12796380
[TBL] [Abstract][Full Text] [Related]
8. Genetic evidence for the multicentric origin of synchronous multiple gastric carcinoma.
Kang GH; Kim CJ; Kim WH; Kang YK; Kim HO; Kim YI
Lab Invest; 1997 Mar; 76(3):407-17. PubMed ID: 9121123
[TBL] [Abstract][Full Text] [Related]
9. [P53 gene mutation in gallbladder cancer].
Roa I; Melo A; Roa J; Araya J; Villaseca M; de Aretxabala X
Rev Med Chil; 2000 Mar; 128(3):251-8. PubMed ID: 10962865
[TBL] [Abstract][Full Text] [Related]
10. Alterations of (CA)n DNA repeats and tumor suppressor genes in human gastric cancer.
Mironov NM; Aguelon MA; Potapova GI; Omori Y; Gorbunov OV; Klimenkov AA; Yamasaki H
Cancer Res; 1994 Jan; 54(1):41-4. PubMed ID: 8261459
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of types of P53 gene mutation in gastric cancer tissues].
Gao Z; Gao Z; Liu X
Zhonghua Yu Fang Yi Xue Za Zhi; 1996 Nov; 30(6):343-6. PubMed ID: 9388909
[TBL] [Abstract][Full Text] [Related]
12. p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas.
Hashimoto T; Tokuchi Y; Hayashi M; Kobayashi Y; Nishida K; Hayashi S; Ishikawa Y; Tsuchiya S; Nakagawa K; Hayashi J; Tsuchiya E
Cancer Res; 1999 Nov; 59(21):5572-7. PubMed ID: 10554037
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of p53 predicts shorter survival in diffuse type gastric cancer.
Lee WJ; Shun CT; Hong RL; Wu MS; Chang KJ; Chen KM
Br J Surg; 1998 Aug; 85(8):1138-42. PubMed ID: 9718015
[TBL] [Abstract][Full Text] [Related]
14. Arginine and proline alleles of the p53 gene are associated with different locations of gastric cancer.
Lai KC; Chen WC; Tsai FJ; Li SY; Jeng LB
Hepatogastroenterology; 2005; 52(63):944-8. PubMed ID: 15966238
[TBL] [Abstract][Full Text] [Related]
15. [Detection and sequence analysis of the p53 gene mutation in epithelial ovarian cancer].
Guan X; Lang J; Bian M
Zhonghua Fu Chan Ke Za Zhi; 1998 Mar; 33(3):165-7. PubMed ID: 10682487
[TBL] [Abstract][Full Text] [Related]
16. Clinical implications of p53 tumor suppressor gene mutation and protein expression in esophageal adenocarcinomas: results of a ten-year prospective study.
Casson AG; Evans SC; Gillis A; Porter GA; Veugelers P; Darnton SJ; Guernsey DL; Hainaut P
J Thorac Cardiovasc Surg; 2003 May; 125(5):1121-31. PubMed ID: 12771886
[TBL] [Abstract][Full Text] [Related]
17. Analysis of p53 abnormalities in endoscopic gastric biopsies.
Imatani A; Sasano H; Asaki S; Toyota T; Saito M; Masuda T; Nagura H
Anticancer Res; 1996; 16(4A):2049-56. PubMed ID: 8712741
[TBL] [Abstract][Full Text] [Related]
18. [p53 gene mutation in cancer of the colon and rectum].
Roa JC; Roa I; Melo A; Araya JC; Villaseca MA; Flores M; Schneider B
Rev Med Chil; 2000 Sep; 128(9):996-1004. PubMed ID: 11349504
[TBL] [Abstract][Full Text] [Related]
19. [High frequency mutation of p53 gene in human gastric cancer and precancerous lesions].
Li Z; Lü Y
Zhonghua Zhong Liu Za Zhi; 1998 Mar; 20(2):90-3. PubMed ID: 10920952
[TBL] [Abstract][Full Text] [Related]
20. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]